A COMPARATIVE STUDY OF THE EFFECTIVENESS OF DILANTIN SODIUM AND PHENOBARBITAL IN A GROUP OF EPILEPTICS
Abstract
1. A comparative study of the effectiveness of phenobarbital and dilantin-sodium on a group of chronic epileptics whose average duration of illness has been 15.6 years was undertaken. While phenobarbital has proven beneficial in most cases, the best results were obtained by using dilantin-sodium, as on the latter drug 40 per cent showed a complete cessation of seizures for a period of three to six months and 13.3 per cent showed a marked diminution in the number of convulsive responses, or a total of 53.3 per cent of improvement.
2. Complications ranging from slight myoclonic tremors to frank psychotic episodes occurred. However, most of them cleared upon withdrawal of the drug or diminution of the dosage.
3. In the treatment of epileptics, the therapy of choice varies with the individual. In our series of cases, dilantin-sodium has been the medication of choice despite its complications and has proven its worth as a valuable adjunct in the treatment of epileptics.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
